Vitamin D3 shows promise for ulcerative colitis in new trial
NCT ID NCT07269223
First seen Jan 10, 2026 · Last updated May 25, 2026 · Updated 21 times
Summary
This study tests whether adding vitamin D3 supplements to standard treatment can lower inflammation in people with moderate ulcerative colitis. Sixty adults aged 20-40 will take either vitamin D3 (50,000 IU every two weeks) or a placebo for 12 weeks. Researchers will measure changes in blood and stool markers of inflammation and track disease activity and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Veterinary & Animal Sciences, Lahore
RECRUITINGLahore, Punjab Province, 54000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.